Can Pyridoxine Successfully Reduce Behavioral Side Effects from Levetiracetam? A Critically Appraised Topic.

Nikita ChhabraAimen VanoodMatthew T HoerthCristina Valencia SanchezCumara B O'Carroll

Published in: The neurologist (2023)

This study suggests that pyridoxine for the treatment of levetiracetam-induced behavioral side effects may result in modest improvement, although many limitations prevent conclusive results. There remains a need for a double-blinded, randomized control trial in both the adult and pediatric populations.

Keyphrases

open label
double blind
high glucose
placebo controlled
young adults
randomized controlled trial
phase ii
clinical trial
combination therapy
drug induced
oxidative stress
study protocol
genetic diversity